Neuland Laboratories Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Neuland Laboratories Limited, explained in plain English.

• ▪Neuland Laboratories Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪Reported fundamentals show a net margin of 20.99%, debt to equity of 16.07.
• ▪Our transparent MaxGrade checklist scores it C (51/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 37.47% with a maximum drawdown of -36.21%.

Last traded values from 6 Oct 2026. Market closed.